Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$177.99
3.011.72%
al cierre: -
$178.38
0.390.22%
After hour: 7:59 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
NVIDIA Corp ha un obiettivo di prezzo di consenso pari a $195.79, stabilito in base alle ultime valutazioni degli analisti di 38. Le ultime 3 valutazioni degli analisti sono state rilasciate da Evercore ISI Group, UBS y Wedbush il agosto 22, 2025, agosto 21, 2025 y agosto 21, 2025. Con un obiettivo di prezzo medio di $209.67 tra le Evercore ISI Group, UBS y Wedbush, c'è un implicito 17.54% upside per NVIDIA Corp da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Evercore ISI Group
UBS
Wedbush
Keybanc
TD Cowen
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para NVIDIA
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/22/2025 | 19.97% | Evercore ISI Group | $190 → $214 | Maintains | Outperform | |||
08/21/2025 | 14.92% | UBS | $175 → $205 | Maintains | Buy | |||
08/21/2025 | 17.73% | Wedbush | $175 → $210 | Maintains | Outperform | |||
08/20/2025 | 20.53% | Keybanc | $190 → $215 | Maintains | Overweight | |||
08/19/2025 | 31.74% | TD Cowen | $140 → $235 | Maintains | Buy | |||
08/18/2025 | 34.54% | Cantor Fitzgerald | $200 → $240 | Maintains | Overweight | |||
08/18/2025 | 15.48% | Morgan Stanley | $200 → $206 | Maintains | Overweight | |||
08/14/2025 | 14.92% | Mizuho | $192 → $205 | Maintains | Outperform | |||
08/13/2025 | 26.14% | Piper Sandler | $180 → $225 | Maintains | Overweight | |||
08/11/2025 | 23.33% | Wells Fargo | $185 → $220 | Maintains | Overweight | |||
08/07/2025 | 12.12% | Goldman Sachs | $185 → $200 | Maintains | Buy | |||
08/04/2025 | 23.33% | B of A Securities | $220 → $220 | Reiterates | Buy → Buy | |||
07/30/2025 | 12.12% | Morgan Stanley | $170 → $200 | Maintains | Overweight | |||
07/16/2025 | 7.64% | Mizuho | $185 → $192 | Maintains | Outperform | |||
07/16/2025 | 12.12% | Needham | $160 → $200 | Maintains | Buy | |||
07/15/2025 | 9.32% | DZ Bank | $160 → $195 | Maintains | Buy | |||
07/15/2025 | 31.74% | Melius Research | $205 → $235 | Maintains | Buy | |||
07/15/2025 | 12.12% | Oppenheimer | $175 → $200 | Maintains | Outperform | |||
07/10/2025 | 3.71% | Goldman Sachs | → $185 | Initiates | → Buy | |||
07/07/2025 | 6.51% | Citigroup | $180 → $190 | Maintains | Buy | |||
07/03/2025 | 3.71% | Mizuho | $170 → $185 | Maintains | Outperform | |||
06/25/2025 | 40.15% | Loop Capital | $175 → $250 | Maintains | Buy | |||
06/17/2025 | 12.12% | Barclays | $170 → $200 | Maintains | Overweight | |||
06/16/2025 | -1.89% | Oppenheimer | $175 → $175 | Reiterates | Outperform → Outperform | |||
05/29/2025 | 17.73% | Truist Securities | $205 → $210 | Maintains | Buy | |||
05/29/2025 | -7.5% | Raymond James | $150 → $165 | Maintains | Strong Buy | |||
05/29/2025 | 0.91% | Piper Sandler | $150 → $180 | Maintains | Overweight | |||
05/29/2025 | -4.7% | Mizuho | $168 → $170 | Maintains | Outperform | |||
05/29/2025 | 0.91% | Citigroup | $150 → $180 | Maintains | Buy | |||
05/29/2025 | -4.7% | Morgan Stanley | $160 → $170 | Maintains | Overweight | |||
05/29/2025 | -4.7% | Barclays | $155 → $170 | Maintains | Overweight | |||
05/29/2025 | -24.32% | DA Davidson | $120 → $135 | Maintains | Neutral | |||
05/29/2025 | 12.12% | Rosenblatt | $178 → $200 | Maintains | Buy | |||
05/29/2025 | 6.51% | Benchmark | $190 → $190 | Reiterates | Buy → Buy | |||
05/29/2025 | -10.3% | Needham | $160 → $160 | Reiterates | Buy → Buy | |||
05/22/2025 | -1.89% | Wedbush | $175 → $175 | Reiterates | Outperform → Outperform | |||
05/14/2025 | -10.3% | B of A Securities | $150 → $160 | Maintains | Buy | |||
05/12/2025 | -1.89% | UBS | $180 → $175 | Maintains | Buy | |||
04/30/2025 | -43.94% | Seaport Global | → $100 | Initiates | → Sell | |||
04/25/2025 | -10.3% | Morgan Stanley | $162 → $160 | Maintains | Overweight | |||
04/23/2025 | -0.21% | Rosenblatt | $200 → $178 | Maintains | Buy | |||
04/22/2025 | -13.11% | Barclays | $175 → $155 | Maintains | Overweight | |||
04/17/2025 | 0.91% | UBS | $185 → $180 | Maintains | Buy | |||
04/16/2025 | 6.51% | Evercore ISI Group | $190 → $190 | Reiterates | Outperform → Outperform | |||
04/16/2025 | 12.12% | Rosenblatt | $220 → $200 | Maintains | Buy | |||
04/16/2025 | -32.73% | DA Davidson | $120 → $120 | Maintains | Neutral | |||
04/16/2025 | -15.91% | Raymond James | $170 → $150 | Maintains | Strong Buy | |||
04/16/2025 | 12.12% | Cantor Fitzgerald | $200 → $200 | Reiterates | Overweight → Overweight | |||
04/16/2025 | -15.91% | Piper Sandler | $175 → $150 | Maintains | Overweight | |||
04/16/2025 | -1.89% | Wedbush | $175 → $175 | Reiterates | Outperform → Outperform | |||
04/16/2025 | -10.3% | B of A Securities | $200 → $160 | Maintains | Buy | |||
04/14/2025 | -32.73% | DA Davidson | $125 → $120 | Maintains | Neutral | |||
04/11/2025 | -15.91% | Citigroup | $163 → $150 | Maintains | Buy | |||
04/09/2025 | -21.52% | TD Cowen | $175 → $140 | Maintains | Buy | |||
03/20/2025 | -29.92% | DA Davidson | $135 → $125 | Maintains | Neutral | |||
03/20/2025 | 6.51% | Benchmark | $190 → $190 | Reiterates | Buy → Buy | |||
03/19/2025 | 0.91% | Susquehanna | $180 → $180 | Maintains | Positive | |||
03/19/2025 | 12.12% | Cantor Fitzgerald | $200 → $200 | Reiterates | Overweight → Overweight | |||
03/19/2025 | — | Keybanc | — | Reiterates | Overweight → Overweight | |||
03/19/2025 | 12.12% | B of A Securities | $200 → $200 | Reiterates | Buy → Buy | |||
03/19/2025 | -10.3% | Needham | $160 → $160 | Reiterates | Buy → Buy | |||
03/19/2025 | 23.33% | Rosenblatt | $220 → $220 | Maintains | Buy | |||
03/19/2025 | 6.51% | Benchmark | $190 → $190 | Reiterates | Buy → Buy | |||
03/14/2025 | -5.82% | Mizuho | $175 → $168 | Maintains | Outperform | |||
02/27/2025 | -24.32% | DA Davidson | $135 → $135 | Maintains | Neutral | |||
02/27/2025 | 12.12% | Cantor Fitzgerald | $200 → $200 | Reiterates | Overweight → Overweight | |||
02/27/2025 | 6.51% | Benchmark | $190 → $190 | Reiterates | Buy → Buy | |||
02/27/2025 | 14.92% | Truist Securities | $204 → $205 | Maintains | Buy | |||
02/27/2025 | -9.18% | Morgan Stanley | $152 → $162 | Maintains | Overweight | |||
02/27/2025 | 12.12% | B of A Securities | $190 → $200 | Maintains | Buy | |||
02/27/2025 | -10.3% | Needham | $160 → $160 | Reiterates | Buy → Buy | |||
02/27/2025 | 23.33% | Rosenblatt | $220 → $220 | Maintains | Buy | |||
02/25/2025 | 6.51% | Evercore ISI Group | $190 → $190 | Reiterates | Outperform → Outperform | |||
02/24/2025 | 23.33% | Rosenblatt | $220 → $220 | Maintains | Buy | |||
02/20/2025 | 6.51% | Keybanc | $180 → $190 | Maintains | Overweight | |||
02/20/2025 | 9.32% | Baird | $195 → $195 | Reiterates | Outperform → Outperform | |||
01/28/2025 | -14.79% | Morgan Stanley | $166 → $152 | Maintains | Overweight | |||
01/28/2025 | 23.33% | Tigress Financial | $170 → $220 | Upgrade | Buy → Strong Buy | |||
01/27/2025 | 12.12% | Cantor Fitzgerald | $200 → $200 | Reiterates | Overweight → Overweight | |||
01/17/2025 | -1.89% | Barclays | $160 → $175 | Maintains | Overweight | |||
01/13/2025 | 3.71% | HSBC | $195 → $185 | Maintains | Buy | |||
01/08/2025 | 23.33% | Rosenblatt | $220 → $220 | Maintains | Buy | |||
01/07/2025 | 6.51% | B of A Securities | $190 → $190 | Reiterates | Buy → Buy | |||
01/07/2025 | 6.51% | Benchmark | $190 → $190 | Reiterates | Buy → Buy | |||
12/20/2024 | -6.94% | Morgan Stanley | $168 → $166 | Maintains | Overweight | |||
12/16/2024 | 14.36% | Truist Securities | $169 → $204 | Maintains | Buy | |||
11/22/2024 | -24.32% | DA Davidson | $90 → $135 | Maintains | Neutral | |||
11/22/2024 | -10.3% | Phillip Securities | $155 → $160 | Downgrade | Buy → Accumulate | |||
11/21/2024 | -5.82% | Morgan Stanley | $160 → $168 | Maintains | Overweight | |||
11/21/2024 | 9.32% | Melius Research | $185 → $195 | Maintains | Buy | |||
11/21/2024 | -1.89% | Craig-Hallum | $165 → $175 | Maintains | Buy | |||
11/21/2024 | -5.26% | Truist Securities | $167 → $169 | Maintains | Buy | |||
11/21/2024 | -1.89% | Wedbush | $160 → $175 | Maintains | Outperform | |||
11/21/2024 | -1.89% | Mizuho | $165 → $175 | Maintains | Outperform | |||
11/21/2024 | -1.89% | TD Cowen | $165 → $175 | Maintains | Buy | |||
11/21/2024 | -1.89% | Citigroup | $170 → $175 | Maintains | Buy | |||
11/21/2024 | -21.52% | Deutsche Bank | $115 → $140 | Maintains | Hold | |||
11/21/2024 | 6.51% | B of A Securities | $190 → $190 | Reiterates | Buy → Buy | |||
11/21/2024 | -1.89% | Oppenheimer | $175 → $175 | Reiterates | Outperform → Outperform | |||
11/21/2024 | -4.7% | JP Morgan | $155 → $170 | Maintains | Overweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de NVIDIA (NVDA)?
El último precio objetivo de NVIDIA (NASDAQ:NVDA) fue comunicado por Evercore ISI Group el agosto 22, 2025. La firma de analistas fijó un precio objetivo para $214.00 que espera NVDA a rise dentro de 12 meses (un posible 19.97% upside). 100 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre NVIDIA (NVDA)?
La última calificación de analistas para NVIDIA (NASDAQ:NVDA) fue proporcionada por Evercore ISI Group, y NVIDIA mantuvo su outperform calificación.
¿Cuándo se produjo la última revisión al alza de NVIDIA (NVDA)?
La última revisión al alza de NVIDIA Corp se produjo en enero 28, 2025, cuando Tigress Financial elevó su precio objetivo a $220. Tigress Financial anteriormente tenía a buy para NVIDIA Corp.
¿Cuándo fue la última revisión a la baja de NVIDIA (NVDA)?
La última revisión a la baja de NVIDIA Corp se produjo en noviembre 22, 2024, cuando Phillip Securities cambió su precio objetivo de $155 a $160 para NVIDIA Corp.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para NVIDIA (NVDA)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de NVIDIA, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de NVIDIA se registró el agosto 22, 2025, por lo que la próxima calificación estará disponible en torno al agosto 22, 2026.
¿Es correcta la calificación de los analistas sobre NVIDIA (NVDA)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de NVIDIA (NVDA) fue un mantuvo con un precio objetivo de $190.00 a $214.00. El precio actual al que cotiza NVIDIA (NVDA) es de $178.38, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.